What is the main objective of a stock comparison between Aflac and MetLife?

The comparison aims to highlight how two insurers differ in business models, growth drivers, and risk profiles. By examining earnings, capital strength, and diversification (e.g., US and Japan markets), readers can understand relative strengths and weaknesses without implying buy or sell actions. It focuses on educational insight into how market context shapes performance.

How should I interpret earnings per share (EPS) differences in the two stocks?

EPS reflects profits allocated to each share. Aflac’s recent EPS beat suggests stronger profitability momentum, while MetLife’s lower valuation metrics imply different market expectations. Compare EPS growth year over year, consistency, and how one-off items might influence quarterly results to avoid misreading temporary spikes.

What does price-to-earnings (P/E) tell me in this context?

P/E compares share price to earnings, indicating how the market values future profitability. In this pair, MetLife shows comparatively lower P/E, possibly reflecting different growth expectations, risk, or capital efficiency. Consider forward P/E alongside earnings quality and sustainability to gauge relative valuation.

Why might diversification across US and Japan markets matter for Aflac versus MetLife?

Diversification affects risk and revenue resilience. Aflac earns in both the US and Japan, potentially smoothing country-specific cycles but introducing exchange and regulatory exposure. MetLife benefits from broader product lines and domestic diversification, which can offer stability though each approach has market-specific risks.

How should I view the stated cons for Aflac in Q3 and its calculation of volatility?

Aflac’s weaker Japan segment and volatility from derivatives and currency moves can impact earnings stability. Consider how much of overall earnings depend on international operations and hedging effectiveness. A higher volatility component may lead to larger swings in reported profits and risk-adjusted returns.

What plant in MetLife’s favour is implied by its lower P/E and forward P/E metrics?

Lower valuation metrics may reflect higher perceived risk, slower growth, or stronger earnings quality. If MetLife sustains durable profits and efficient capital use, the lower P/E could translate into higher future total returns. Compare with Aflac’s higher valuation to assess relative upside potential.

How does market volatility influence decisions when comparing these two stocks?

Volatility indicates how much stock prices move, influencing risk appetite. MetLife is noted as more volatile than Aflac, suggesting higher short-term risk for investors seeking stability. Evaluate your own tolerance for price swings and consider long-term fundamentals beyond daily moves.

What does the concept of maximum drawdown reveal in the two stocks?

Maximum drawdown measures the greatest decline from a peak to a trough. Similar drawdown histories imply comparable downside risk during stress. Use this alongside volatility and liquidity to assess how each stock might withstand adverse market conditions.

How should I use book value per share in evaluating these insurers?

Book value per share represents the net asset value per share. A lower level for MetLife compared with Aflac could indicate less equity buffer or slower growth in book value. Interpret it with profitability, asset quality, and capital efficiency to understand financial strength.

What is the best way to read ‘pros and cons’ in this comparison page?

Pros and cons summarise recent performance signals and structural features. Read them as prompts to investigate underlying drivers: earnings quality, market exposure, and competitive positioning. Always corroborate with additional data like cash flow, dividends, and regulatory context before drawing conclusions.

What role do corporate actions and product launches play in these stocks’ prospects?

Product launches and strategic initiatives can drive earnings growth and differentiation. For Aflac, such moves may bolster revenues in US/Japan markets, while MetLife’s diversified product lines could broaden sales channels. Track execution quality and market reception to assess potential impact.

Educational disclaimer

Educational disclaimer: The information presented is for understanding how to read a stock comparison and is not financial advice. It uses public information and hypothetical analysis to illustrate concepts relevant to Aflac and MetLife within the given context.

Aflac vs MetLife

Aflac dominates the supplemental health and life insurance market in Japan and the U.S. with a brand so recognizable the duck does the selling, while MetLife operates a global insurance giant spanning group benefits, individual protection, and retirement products across dozens of countries. Both companies are disciplined capital returners with long track records of navigating interest rate cycles and managing actuarial risk. The Aflac vs MetLife comparison reveals how each positions its product mix for a changing demographic landscape, sustains margins in low-rate environments, and returns excess capital to shareholders.

Comparison Snapshot

Key Financial Metrics

AFL

Metric

MET

$59.31B

Market Cap

$49.60B

-4.70%

Potential Profit

19.00%

Hold

Analyst Rating

Buy

Discover More Comparisons

Aflac vs Manulife

Aflac dominates supplemental insurance in the U.S. and Japan through its iconic duck-branded voluntary benefits products, while Manulife is a diversified Canadian insurer with major wealth management and life insurance operations across Asia. Aflac vs Manulife both collect premiums and invest float, but Aflac's simplicity and Japan concentration differ sharply from Manulife's broader geographic and product diversification. Readers uncover how policyholder growth, investment yield sensitivity, and capital return programs compare between these two insurance titans.

Aflac vs Truist

Aflac prints steady supplemental insurance premiums in the US and Japan, while Truist operates as a top-ten bank with a massive lending book and fee businesses built from the BB&T and SunTrust merger. Both are large-cap financial services companies that live and die by interest rate cycles and credit quality. The Aflac vs Truist comparison exposes how policyholder persistency and claim ratios drive one firm's earnings while net interest margin compression or expansion steers the other's bottom line.

NatWest vs MetLife

NatWest has spent years rebuilding its franchise after the UK government bailout while MetLife runs one of the world's largest life insurance and benefits platforms with a far more global footprint. Both are financial institutions with massive balance sheets that generate returns through spread management and fee income, and both must satisfy regulators who've only grown more demanding since the financial crisis. NatWest vs MetLife examines capital ratios, return on equity trajectories, and which company's restructuring story has more runway left to deliver shareholder value.

Investment Analysis

Aflac

AFL

Pros

Aflac delivered a strong Q3 2025 with EPS surpassing forecasts by over 40%, improving year-over-year by 15.3%.
The company maintains strong capital ratios and liquidity, supporting financial stability and operational flexibility.
Aflac benefits from diversified revenue streams across U.S. and Japan markets, with strategic initiatives including new product launches and technology upgrades.

Considerations

The Japan segment experienced a 4% decline in net earned premiums, indicating challenges in its key international market.
Aflac’s valuation metrics such as price-to-earnings and price-to-sales ratios are higher than MetLife, suggesting the stock might be relatively expensive.
Investment gains in Q3 included volatile components such as derivatives and foreign currency, potentially adding earnings volatility.

MetLife

MET

Pros

MetLife shows stronger valuation and enterprise metrics overall, including lower P/E and forward P/E ratios relative to Aflac.
The company has a lower price-to-sales ratio, suggesting a potentially more attractive valuation on sales metrics than Aflac.
MetLife operates with broader revenue diversification which gives it a competitive advantage across multiple insurance product lines.

Considerations

MetLife has exhibited higher stock price volatility compared to Aflac, reflecting potentially increased market risk.
Despite its size, MetLife’s maximum drawdown history is similar to Aflac’s, indicating comparable downside risk during market stress.
The lower book value per share compared to Aflac could imply less equity buffer against risks or slower growth in book value.

About Aflac and MetLife

Aflac (AFL)

Aflac Inc. is a major player in the insurance world, providing financial protection to millions of people. The company's main business is offering supplemental health and life insurance, which is designed to help policyholders cover costs that their primary insurance might not. Aflac operates through two main segments: Aflac U.S. and Aflac Japan. Its presence in Japan is particularly noteworthy, where it stands as a leading provider of cancer and medical insurance policies. In the United States, its products serve as an extra layer of financial security for individuals who already have major medical coverage. This dual-market strategy has helped Aflac build a significant global footprint. As with any investment, it's important to remember that a company's past performance doesn't guarantee future returns, and the value of investments can go down as well as up.

MetLife (MET)

MetLife, Inc. is a major player in the global financial services industry, offering a broad range of products including insurance, annuities, employee benefits, and asset management. The company serves a diverse client base, from individuals to large institutions, across numerous countries. Its operations are structured into several key segments, covering the Americas, Asia, and Europe, the Middle East, and Africa (EMEA). This gives the company a significant footprint in both developed and emerging markets. For investors, MetLife represents a large, established organisation within the insurance sector. However, like any investment, its value can fluctuate based on market conditions, regulatory changes, and company performance, and returns are not guaranteed. It's important for potential investors to consider if this stock aligns with their own financial goals and risk tolerance.

Buy AFL or MET in Nemo

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Aflac vs MetLife

Comparison Snapshot